These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22437141)

  • 1. Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment.
    Peter-Derex L; Devic P; Rogemond V; Rheims S; Mauguière F; Honnorat J
    Sleep Med; 2012 May; 13(5):554-6. PubMed ID: 22437141
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies.
    Modoni A; Masciullo M; Spinelli P; Marra C; Tartaglione T; Andreetta F; Tonali P; Silvestri G
    Cogn Behav Neurol; 2009 Mar; 22(1):63-6. PubMed ID: 19372772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of limbic encephalitis with anti-glioma-inactivated 1 (LGI1) antibodies.
    Krastinova E; Vigneron M; Le Bras P; Gasnault J; Goujard C
    J Clin Neurosci; 2012 Nov; 19(11):1580-2. PubMed ID: 22925419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune limbic encephalitis with anti-NMDA receptor antibodies and ovarian teratoma: a treatable form of paraneoplastic limbic encephalitis].
    Henry C; Husson H; de Broucker T
    Rev Neurol (Paris); 2009 Jan; 165(1):70-5. PubMed ID: 18809188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over 10-year follow-up of limbic encephalitis associated with anti-LGI1 antibodies.
    Agazzi P; Bien CG; Staedler C; Biglio V; Gobbi C
    J Neurol; 2015 Feb; 262(2):469-70. PubMed ID: 25504306
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulation with intravenous immunoglobulin.
    Hall PD
    Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agrypnia excitata as the main feature in anti-leucine-rich glioma-inactivated 1 encephalitis: a detailed clinical and polysomnographic semiological analysis.
    Piffer S; Cantalupo G; Filipponi S; Poretto V; Pellegrini M; Tanel R; Buganza M; Giometto B
    Eur J Neurol; 2022 Mar; 29(3):890-894. PubMed ID: 34679240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil.
    Saidha S; Murphy S; Ronayne A; McCarthy P; Hennessy MJ; Counihan T
    J Neurol; 2010 Jun; 257(6):1035-8. PubMed ID: 20130897
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare case of limbic encephalitis with anti leucine-rich glioma inactivated-1 (LGI1) antibodies.
    Shen N; Ren H; Wu J; Feng J; Cui L; Fang S
    Neuro Endocrinol Lett; 2014; 35(2):95-7. PubMed ID: 24878970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the clinical features of LGI1 antibody encephalitis.
    Zhao PP; Zhang Y; Gao L; Sun L
    Acta Neurol Belg; 2016 Mar; 116(1):109-12. PubMed ID: 26220774
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune Limbic Encephalitis Associated with Type 1 Diabetes Mellitus.
    Akın O; Kılınç Uğurlu A; Akbaş ED; Döğer E; Akbaş Y; Bideci A; Yüce Ö; Gücüyener K; Çamurdan MO; Karabacak N; Cinaz P
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):387-388. PubMed ID: 28720552
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical analysis of anti-Ma2-associated encephalitis.
    Dalmau J; Graus F; Villarejo A; Posner JB; Blumenthal D; Thiessen B; Saiz A; Meneses P; Rosenfeld MR
    Brain; 2004 Aug; 127(Pt 8):1831-44. PubMed ID: 15215214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy.
    Brown MP; Hissaria P; Hsieh AH; Kneebone C; Vallat W
    J Neuroimmunol; 2017 Apr; 305():16-18. PubMed ID: 28284337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-glutamic Acid decarboxylase antibody associated limbic encephalitis in a child: expanding the spectrum of pediatric inflammatory brain diseases.
    Mishra N; Rodan LH; Nita DA; Gresa-Arribas N; Kobayashi J; Benseler SM
    J Child Neurol; 2014 May; 29(5):677-83. PubMed ID: 24092895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up.
    van Sonderen A; Thijs RD; Coenders EC; Jiskoot LC; Sanchez E; de Bruijn MA; van Coevorden-Hameete MH; Wirtz PW; Schreurs MW; Sillevis Smitt PA; Titulaer MJ
    Neurology; 2016 Oct; 87(14):1449-1456. PubMed ID: 27590293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pearls & Oy-sters: Limbic encephalitis associated with positive anti-LGI1 and antithyroid antibodies.
    Wang SJ; Zhao YY; Wang QZ; Guo B; Liu YM; Yan CZ
    Neurology; 2016 Jan; 86(2):e16-8. PubMed ID: 26755620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limbic encephalitis with severe sleep disorder associated with voltage-gated potassium channels (VGKCs) antibodies].
    Montiel P; Sellal F; Clerc C; Richard P; Bataillard M
    Rev Neurol (Paris); 2008 Feb; 164(2):181-4. PubMed ID: 18358878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for Refractory Autoimmune Encephalitis.
    Yang J; Liu X
    Front Immunol; 2021; 12():790962. PubMed ID: 34975890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGI1 antibody encephalitis: acute treatment comparisons and outcome.
    Rodriguez A; Klein CJ; Sechi E; Alden E; Basso MR; Pudumjee S; Pittock SJ; McKeon A; Britton JW; Lopez-Chiriboga AS; Zekeridou A; Zalewski NL; Boeve BF; Day GS; Gadoth A; Burkholder D; Toledano M; Dubey D; Flanagan EP
    J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):309-315. PubMed ID: 34824144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis.
    Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; Martínez-Rodriguez JE; Vincent A; Santamaría J
    Ann Neurol; 2006 Jan; 59(1):178-81. PubMed ID: 16278841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.